Home/ Stocks/ CRL

Charles River Laboratories International, Inc.

CRL XNYS

$267.49 +1.98 (+0.75%) ▲ 15-min delayed

Open

$261.53

High

$267.59

Low

$260.82

Volume

612.5K

Market Cap

$12.68B

About Charles River Laboratories International, Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Sector: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Employees: 19.7K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$1.00B	$-760,000	$-0.03
Q1 2026	$995.83M	$-14,802,000	$-0.30
FY 2025	$4.02B	$-142,163,000	$-2.91
Q3 2025	$1.00B	$55.56M	$1.11

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 3, 2026

Calendar →

Related Market News

No specific coverage for CRL yet. Check out our latest market news or earnings calendar.

Get CRL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Charles River Laboratories International, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.